{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T16:36:49Z","timestamp":1783528609984,"version":"3.55.0"},"reference-count":36,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2018.1054","type":"journal-article","created":{"date-parts":[[2018,8,3]],"date-time":"2018-08-03T19:57:52Z","timestamp":1533326272000},"page":"e181054","source":"Crossref","is-referenced-by-count":24,"title":["Survival Rates for Patients With Barrett High-grade Dysplasia and Esophageal Adenocarcinoma With or Without Human Papillomavirus Infection"],"prefix":"10.1001","volume":"1","author":[{"given":"Shanmugarajah","family":"Rajendra","sequence":"first","affiliation":[{"name":"Gastro-Intestinal Viral Oncology Group, Ingham Institute for Applied Medical Research, Liverpool, New South Wales, Australia"},{"name":"South Western Sydney Clinical School, University of New South Wales, Kensington, New South Wales, Australia"},{"name":"Department of Gastroenterology & Hepatology, Bankstown-Lidcombe Hospital, South Western Sydney Local Health Network, Bankstown, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xuan","sequence":"additional","affiliation":[{"name":"Ingham Institute for Applied Medical Research, Liverpool, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Merrett","sequence":"additional","affiliation":[{"name":"Discipline of Surgery, School of Medicine, Western Sydney University, Penrith, New South Wales, Australia"},{"name":"Department of Upper Gastrointestinal Surgery, Bankstown-Lidcombe Hospital, Bankstown, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preeti","family":"Sharma","sequence":"additional","affiliation":[{"name":"Gastro-Intestinal Viral Oncology Group, Ingham Institute for Applied Medical Research, Liverpool, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prateek","family":"Sharma","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Veterans Affairs Medical Center and University of Kansas School of Medicine, Kansas City, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren","family":"Pavey","sequence":"additional","affiliation":[{"name":"Gastro-Intestinal Viral Oncology Group, Ingham Institute for Applied Medical Research, Liverpool, New South Wales, Australia"},{"name":"South Western Sydney Clinical School, University of New South Wales, Kensington, New South Wales, Australia"},{"name":"Department of Gastroenterology & Hepatology, Bankstown-Lidcombe Hospital, South Western Sydney Local Health Network, Bankstown, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Yang","sequence":"additional","affiliation":[{"name":"Gastro-Intestinal Viral Oncology Group, Ingham Institute for Applied Medical Research, Liverpool, New South Wales, Australia"},{"name":"South Western Sydney Clinical School, University of New South Wales, Kensington, New South Wales, Australia"},{"name":"SydPath, St Vincent\u2019s Hospital Sydney, Darlinghurst, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo D.","family":"Santos","sequence":"additional","affiliation":[{"name":"Department of Anatomical Pathology, Sydney South West Pathology Service, Liverpool Hospital, Liverpool, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Sharaiha","sequence":"additional","affiliation":[{"name":"South Western Sydney Clinical School, University of New South Wales, Kensington, New South Wales, Australia"},{"name":"Department of Gastroenterology & Hepatology, Bankstown-Lidcombe Hospital, South Western Sydney Local Health Network, Bankstown, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Girish","family":"Pande","sequence":"additional","affiliation":[{"name":"Department of Surgery, Launceston General Hospital, Launceston, Tasmania, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Cosman","sequence":"additional","affiliation":[{"name":"Graduate School of Medicine and Illawara Health and Medical Research Institute, University of Wollongong, Wollongong, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojuan","family":"Wu","sequence":"additional","affiliation":[{"name":"Immunohistochemistry and Molecular Pathology Unit, NSW Health Pathology, Liverpool, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Wang","sequence":"additional","affiliation":[{"name":"Gastro-Intestinal Viral Oncology Group, Ingham Institute for Applied Medical Research, Liverpool, New South Wales, Australia"},{"name":"South Western Sydney Clinical School, University of New South Wales, Kensington, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2018,8,3]]},"reference":[{"issue":"2","key":"zoi180073r1","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1093\/jnci\/dji024","article-title":"The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence.","volume":"97","author":"Pohl","year":"2005","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"zoi180073r2","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1111\/j.1572-0241.2003.07454.x","article-title":"Temporal trends (1973-1997) in survival of patients with esophageal adenocarcinoma in the United States: a glimmer of hope?","volume":"98","author":"Eloubeidi","year":"2003","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"zoi180073r3","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1002\/ijc.25701","article-title":"No further increase in the incidence of esophageal adenocarcinoma in Sweden.","volume":"129","author":"Lagergren","year":"2011","journal-title":"Int J Cancer"},{"issue":"6","key":"zoi180073r4","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1158\/1055-9965.EPI-10-0012","article-title":"Esophageal adenocarcinoma incidence: are we reaching the peak?","volume":"19","author":"Pohl","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"7","key":"zoi180073r5","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1038\/ajg.2013.94","article-title":"Transcriptionally active human papillomavirus is strongly associated with Barrett\u2019s dysplasia and esophageal adenocarcinoma.","volume":"108","author":"Rajendra","year":"2013","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"zoi180073r6","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1038\/ajg.2013.206","article-title":"Viral load and integration status of high-risk human papillomaviruses in the Barrett\u2019s metaplasia-dysplasia-adenocarcinoma sequence.","volume":"108","author":"Wang","year":"2013","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"zoi180073r7","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1016\/j.cgh.2014.11.017","article-title":"Persistence of human papillomavirus, overexpression of p53, and outcomes of patients after endoscopic ablation of Barrett\u2019s esophagus.","volume":"13","author":"Rajendra","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"zoi180073r8","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1136\/jmedgenet-2015-103411","article-title":"Genomic analysis of HPV-positive versus HPV-negative oesophageal adenocarcinoma identifies a differential mutational landscape.","volume":"53","author":"Rajendra","year":"2016","journal-title":"J Med Genet"},{"issue":"10","key":"zoi180073r9","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1002\/ijc.v141.10","article-title":"Active human papillomavirus involvement in Barrett\u2019s dysplasia and oesophageal adenocarcinoma is characterized by wild-type p53 and aberrations of the retinoblastoma protein pathway.","volume":"141","author":"Rajendra","year":"2017","journal-title":"Int J Cancer"},{"issue":"5","key":"zoi180073r10","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1111\/dote.2013.26.issue-5","article-title":"Human papillomavirus and the risk of Barrett\u2019s esophagus.","volume":"26","author":"El-Serag","year":"2013","journal-title":"Dis Esophagus"},{"issue":"2","key":"zoi180073r11","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.jcv.2008.07.004","article-title":"Human papillomavirus infection in Barrett\u2019s oesophagus in the UK: an infrequent event.","volume":"43","author":"Rai","year":"2008","journal-title":"J Clin Virol"},{"issue":"3","key":"zoi180073r12","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jcv.2010.11.015","article-title":"Human papillomavirus is detectable in Barrett\u2019s esophagus and esophageal carcinoma but is unlikely to be of any etiologic significance.","volume":"50","author":"Iyer","year":"2011","journal-title":"J Clin Virol"},{"key":"zoi180073r13","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.canep.2016.05.004","article-title":"Human papillomavirus not detected in esophageal adenocarcinoma tumor specimens-Letter.","volume":"43","author":"Rajendra","year":"2016","journal-title":"Cancer Epidemiol"},{"key":"zoi180073r14","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.canep.2016.01.014","article-title":"Human papillomavirus not detected in esophageal adenocarcinoma tumor specimens.","volume":"41","author":"Antonsson","year":"2016","journal-title":"Cancer Epidemiol"},{"issue":"3","key":"zoi180073r15","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1111\/apt.12574","article-title":"Systematic review with meta-analysis: the association between human papillomavirus infection and oesophageal cancer.","volume":"39","author":"Li","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"issue":"7","key":"zoi180073r16","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1097\/MEG.0000000000000868","article-title":"The prevalence of viral agents in esophageal adenocarcinoma and Barrett\u2019s esophagus: a systematic review.","volume":"29","author":"Kunzmann","year":"2017","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"8","key":"zoi180073r17","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1002\/(ISSN)1097-0215","article-title":"Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis.","volume":"121","author":"Ragin","year":"2007","journal-title":"Int J Cancer"},{"issue":"12","key":"zoi180073r18","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/j.oraloncology.2012.06.019","article-title":"Human papillomavirus related head and neck cancer survival: a systematic review and meta-analysis.","volume":"48","author":"O\u2019Rorke","year":"2012","journal-title":"Oral Oncol"},{"issue":"6","key":"zoi180073r19","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","article-title":"The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM.","volume":"17","author":"Edge","year":"2010","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"zoi180073r20","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1002\/ijc.v133.6","article-title":"Identification of oropharyngeal squamous cell carcinomas with active HPV16 involvement by immunohistochemical analysis of the retinoblastoma protein pathway.","volume":"133","author":"Holzinger","year":"2013","journal-title":"Int J Cancer"},{"issue":"4","key":"zoi180073r21","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/jnci\/djn011","article-title":"Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.","volume":"100","author":"Fakhry","year":"2008","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"zoi180073r22","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1056\/NEJMoa0912217","article-title":"Human papillomavirus and survival of patients with oropharyngeal cancer.","volume":"363","author":"Ang","year":"2010","journal-title":"N Engl J Med"},{"issue":"25","key":"zoi180073r23","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1056\/NEJMoa073770","article-title":"TP53 mutations and survival in squamous-cell carcinoma of the head and neck.","volume":"357","author":"Poeta","year":"2007","journal-title":"N Engl J Med"},{"issue":"10","key":"zoi180073r24","first-page":"3430","article-title":"Prognostic significance of high-risk human papillomavirus and p16(INK4A) in patients with esophageal squamous cell carcinoma.","volume":"7","author":"Cao","year":"2014","journal-title":"Int J Clin Exp Med"},{"issue":"16","key":"zoi180073r25","doi-asserted-by":"publisher","first-page":"7161","DOI":"10.7314\/APJCP.2015.16.16.7161","article-title":"p16 expression as a surrogate marker for HPV infection in esophageal squamous cell carcinoma can predict response to neo-adjuvant chemotherapy.","volume":"16","author":"Kumar","year":"2015","journal-title":"Asian Pac J Cancer Prev"},{"key":"zoi180073r26","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13027-017-0163-4","article-title":"HPV infection and p53 and p16 expression in esophageal cancer: are they prognostic factors?","volume":"12","author":"da Costa","year":"2017","journal-title":"Infect Agent Cancer"},{"issue":"3","key":"zoi180073r27","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1136\/gutjnl-2015-310888","article-title":"The prognostic value of TP53 mutations in oesophageal adenocarcinoma: a systematic review and meta-analysis.","volume":"66","author":"Fisher","year":"2017","journal-title":"Gut"},{"issue":"11","key":"zoi180073r28","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1056\/NEJM199503163321104","article-title":"Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck.","volume":"332","author":"Brennan","year":"1995","journal-title":"N Engl J Med"},{"issue":"11","key":"zoi180073r29","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1093\/annonc\/mdt319","article-title":"Human papillomavirus detection and comorbidity: critical issues in selection of patients with oropharyngeal cancer for treatment de-escalation trials.","volume":"24","author":"Rietbergen","year":"2013","journal-title":"Ann Oncol"},{"issue":"5381","key":"zoi180073r30","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1126\/science.281.5381.1322","article-title":"The Bcl-2 protein family: arbiters of cell survival.","volume":"281","author":"Adams","year":"1998","journal-title":"Science"},{"issue":"1","key":"zoi180073r31","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/(ISSN)1097-4644","article-title":"BCL-2 family proteins: regulators of cell death involved in the pathogenesis of cancer and resistance to therapy.","volume":"60","author":"Reed","year":"1996","journal-title":"J Cell Biochem"},{"issue":"7","key":"zoi180073r32","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1158\/1535-7163.MCT-05-0081","article-title":"Reversal of cisplatin resistance with a BH3 mimetic, (-)-gossypol, in head and neck cancer cells: role of wild-type p53 and Bcl-xL.","volume":"4","author":"Bauer","year":"2005","journal-title":"Mol Cancer Ther"},{"issue":"32","key":"zoi180073r33","doi-asserted-by":"publisher","first-page":"4294","DOI":"10.1200\/JCO.2011.36.4596","article-title":"Human papillomavirus and rising oropharyngeal cancer incidence in the United States.","volume":"29","author":"Chaturvedi","year":"2011","journal-title":"J Clin Oncol"},{"issue":"7","key":"zoi180073r34","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1097\/PAS.0b013e31816380ec","article-title":"Basaloid squamous cell carcinoma of the head and neck is a mixed variant that can be further resolved by HPV status.","volume":"32","author":"Begum","year":"2008","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"zoi180073r35","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.1002\/(ISSN)1097-0215","article-title":"Marked differences in survival rate between smokers and nonsmokers with HPV 16-associated tonsillar carcinomas.","volume":"122","author":"Hafkamp","year":"2008","journal-title":"Int J Cancer"},{"issue":"12","key":"zoi180073r36","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1136\/gutjnl-2012-303594","article-title":"Aberrant p53 protein expression is associated with an increased risk of neoplastic progression in patients with Barrett\u2019s oesophagus.","volume":"62","author":"Kastelein","year":"2013","journal-title":"Gut"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/\/jamanetworkopen\/article-pdf\/1\/4\/e181054\/17313746\/rajendra_2018_oi_180073.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,28]],"date-time":"2022-08-28T19:07:33Z","timestamp":1661713653000},"score":1,"resource":{"primary":{"URL":"http:\/\/jamanetworkopen.jamanetwork.com\/article.aspx?doi=10.1001\/jamanetworkopen.2018.1054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,3]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,8,3]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2018.1054","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,3]]}}}